Connection
Lisa Brents to Metabolic Detoxication, Phase I
This is a "connection" page, showing publications Lisa Brents has written about Metabolic Detoxication, Phase I.
|
|
Connection Strength |
|
 |
|
 |
|
0.385 |
|
|
|
-
Brents LK, Reichard EE, Zimmerman SM, Moran JH, Fantegrossi WE, Prather PL. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One. 2011; 6(7):e21917.
Score: 0.385